Back to search

National and Kapodistrian University of Athens

Ηλεκτροφυσιολογική και βιοχημική μελέτη υποδοχέων σχετιζομένων με ασθένειες του κεντρικού νευρικού συστήματος

Abstract

dc:description

Neuronal nicotinic acetylcholine receptors (nAChRs) are located mainly in the Central Nervous System (CNS) where they regulate the release of neurotransmitters and mediate fast neurotransmission. Neurotransmitters transfer the information from a neuron to an adjacent neuron or muscle cell. Some examples of neurotransmitters are acetylcholine (ACh), serotonin, γ-aminobutyric acid (GABA) and glycine. nAChRs belong to the ‘Cys-loop’ super-family of pentameric ligand-gated ion channels (pLGIC), since this type of receptors possess a characteristic loop formed by 13 highly conserved amino acids between two cysteine (Cys) residues bridged by a disulfide bond, at the N-terminal extracellular domain (ECD). Moreover the Cys-loop superfamily includes the γ-aminobutyric acid (GABAA and GABAC), glycine and serotonin (5-HT3) receptors. They consist of the combination of 9 α (α2-α10) and 3 β (β2-β4) subunits and they are distributed ubiquitously in the brain. The neuronal nAChRs exist either as homopentameric or as heteropentameric molecules. The α7 and α9 subunits are the only known human nAChR subunits that can form homopentamers. They are implicated in various neurological diseases, such as Alzheimer and Parkinson diseases, epilepsy, attention deficit hyperactivity disorder, depression, neuropathic pain and substance addiction. Thus, drug development for these receptors is a priority. These neurotransmitters bind to the ECD of the corresponding receptors, thus, it is very important to know the 3D structure of this region. In general, the ECD of neuronal nAChRs, consists of an N-terminal α-helix and a hydrophobic core of 10 β-strands (β1-β10). Some of the characteristic loops, linking these β-strands, contribute to the formation of the ligand- binding site. Loops A, B, and C contribute to the formation of the primary (+) binding site, whereas the loops D, E and F conferred from the adjacent subunit form the complementary (-) side of the ligand binding site.The principal binding sides of the neuronal nAChRs are very homologous among the various subunits, whereas there is little conservation in the complementary sides, which are those that confer selectivity to various drugs. Thus, in order to design highly specific and effective drugs towards a specific nAChR subtype and avoid side-effects, its in-depth structural and functional information is highly needed. Towards this aim, members of our laboratory have recently acquired important structural crystallographic data for the ECDs of two subunits of human nAChRs: the α9 and α2. In the nature, the α9 subunit forms either homopentamers or heteropentamers with α10, whereas α2 is known to form heteropentamers with the β2 subunit. It is worth mentioning that α2 presents high homology with the α4 subunit (78%), which is the most commonly found nAChR subunit in the human brain. In the above studies, the crystal structures of the ECDs of the human α9 and α2 subunits were presented. The structure of α9-ECD was determined as a monomer in its free-state and in its complexes with the antagonists methylcaconitine (MLA) and α-Bungarotoxin (α-Bgtx), whereas α2-ECD was crystallized as a homopentamer in complex with the agonist Epibatidine (Epi). In the present thesis, some characteristic structural elements and interactions, revealed from these structural studies on the α9 and α2 ECDs were evaluated regarding their functional impact by electrophysiological studies. More specifically, the structure of α9-ECD revealed a novel β7-β10 strand interaction between Thr203 (invariant in nAChR α subunits) and Thr147 (unique in α9 and in α10). Subsequent electrophysiological studies performed in this thesis, showed that this unique β7-β10 strand interaction in α9 nAChRs is critical for coupling agonist binding to gating. Moreover, based on the X-ray crystal structure of α2-ECD, we provided electrophysiological data on structural elements which are involved in ligand binding and/or the activation and desensitization of α2β2 nAChRs.It is worth mentioning that α2β2 nAChR has two subtypes or stoichiometries: the (α2)3(β2)2, which is the low-sensitivity (to agonists) subtype (LS) and the (α2)2(β2)3, which is the high-sensitivity (HS) subtype. We evaluated the functional role of an invariable α2 residue, Trp84, which is located on loop D of the complementary side of α2, and showed that this residue is involved in the ACh-binding ability, potency and desensitization rate of the LS-subtype of α2β2 nAChR. More importantly, through mutational and subsequent electrophysiological studies on the α2 subunit, we provided solid evidence for the presence of the α2(+)/α2(−) binding site on the α2β2 LS subtype. Also, in the α2-Epi structure, loop F found at a very close proximity to loop C, as the side-chain of Tyr199 (Loop C) forms a hydrogen bond with the backbone carbonyl Cys221 (loop F). Thus, we investigated the functional role of Tyr199 on the minus side of α2 and the corresponding residue Phe169 on the minus side β2 subunit through single-point mutations and subsequent electrophysiological analysis. We showed that loop F has a distinct role on these two subunits since mutation of a particular amino acid residue of the loop seemed to have significant effects on the EC50 values of ACh on both LS and HS subtypes of α2β2 nAChR.In conclusion, following structure-guided mutagenesis, the electrophysiological data presented in the current thesis, confirmed the presence of the α2(+)/α2(-) binding site on the LS α2β2 subtype and validated the functional significance of specific amino acid residues in the α2 and β2 nAChR subunits. Given the pathological importance of the α2 subunit and the high sequence identity with α4 (78%) and with other neuronal nAChR subunits, our findings offer valuable information for modeling several nAChRs and ultimately for structure based design of subtype specific drugs against the nAChR- associated diseases.In addition, in collaboration with Dr Matsa’s and Dr Thomaidou Labs we have obtained electrophysiological data in two projects involving induced pluripotent stem cell–derived neurons for the research of Parkinson disease (PD) and reprogramming astrocytes to neurons. Parkinson disease (PD) is an incurable neurodegenerative disorder, characterized by motor and non-motor deficits, including cognitive decline and dementia. The protein α-Synuclein is strongly associated with PD pathogenesis, whereas α-Synuclein mutations, such as p.A53T, cause familial forms of PD. The question to be addressed by electrophysiology was whether the induced neurons had reached such a maturation degree so as to present the electrical properties of neurons. Indeed our electrophysiological data showed that these cells exhibited electrical properties of neurons. Lastly, our electrophysiological data demonstrated that overexpression of Cend1, in conjunction with neurogenin-2 at high levels leads the nerve stem/progenitor cells to exit the cell cycle and differentiate specifically to the neuronal phenotype. Specifically, the electrophysiological study showed that these cells had electrical properties of neurons.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chroni, Dafni
  • Χρόνη, Δάφνη

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43453

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chroni, Dafni; Χρόνη, Δάφνη. Ηλεκτροφυσιολογική και βιοχημική μελέτη υποδοχέων σχετιζομένων με ασθένειες του κεντρικού νευρικού συστήματος. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43453